Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300077283Phase 4Recruiting
Phase 4, randomised trial of esketamine, alfentanil and propofol (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Incidence of respiratory depression and Incidence of adverse events (circulatory system). Started Nov 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300077283.